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Infant formula based on pea (Pisum sativum)-protein isolate has been suggested as an alternative
to soyabean formula in countries where soyabean is not a native crop, or when soyabean protein
cannot be used due to allergic reactions or intolerances. In the present study, Fe absorption from
experimental infant formulas based on pea-protein isolate was measured in healthy non-anaemic
young women. The influence of phytic acid and ascorbic acid on Fe absorption was evaluated,
using a stable-isotope technique based on incorporation of Fe stable-isotope labels into
erythrocytes 14 d after administration. Geometric mean Fe absorption increased from 20´7
(+1SD 41´6, 21SD 10´3) % to 33´1 (+1SD 58´6, 21SD 18´7) %; P , 0´0001; n 10) after enzymic
degradation of virtually all phytic acid. Doubling the molar ratio Fe : ascorbic acid from 1 : 2´1 to
1 : 4´2 in the infant formula with native phytic acid content also increased Fe absorption
significantly P , 0´0001; n 10); geometric mean Fe absorption increased from 14´8 (+1SD 32´1,
21SD 6´8) % to 22´1 (+1SD 47´2, 21SD 10´4) %. These results confirm the inhibitory and
enhancing effects of phytic acid and ascorbic acid respectively on Fe absorption, but also
indicate relatively high fractional Fe absorption from the pea-protein-based formulas. After
adjusting for differences in Fe status, our data indicate that Fe absorption from dephytinised pea
protein might be less inhibitory than dephytinised soyabean protein as measured in a previous
study (Hurrell et al. 1998).
Pea protein: Phytic acid: Ascorbic acid: Iron: Stable isotopes
Most infant formulas are based on cow's milk, although
commercial products based on soyabean-protein isolate are
available in many countries. Alternative protein sources,
such as pea (Pisum sativum) protein, have been suggested
as interesting novel raw materials for infant formula
production in countries where soyabean is not a native
crop, or in situations where a vegetable-protein-based
formula is desirable and soyabean protein cannot be used
due to allergic reactions or intolerances. Infant formulas
based on soyabean protein have been used for a long time,
and the nutritional status of infants fed soyabean formula
has been well documented and found to be equivalent to
infants fed cow's milk formula. However, the bioavail-
ability of nutrients, especially minerals and trace elements,
has been reported to be lower than that from milk-based
formulas (Golden & Golden, 1981; SandstroÈm et al. 1983;
Gillooly et al. 1984).
An important factor contributing to the reduced
bioavailability of minerals and trace elements from
soyabean formula is the relatively high concentration of
the metal chelator, phytic acid, present in the soyabean-
protein isolate. Phytic acid is an inhibitor of mineral
and trace element absorption, and is a particularly
strong inhibitor of Fe absorption (Hurrell et al. 1992).
The negative effect of phytic acid on Fe absorption has
been shown to be dose-dependent in human subjects
(Hallberg et al. 1989; Siegenberg et al. 1991). In
addition to the influence of phytic acid, soyabean protein
per se has been demonstrated to inhibit Fe absorption
(Lynch et al. 1994). Fe absorption, however, depends on
the balance between dietary inhibitors (e.g. phytic acid)
and enhancers of absorption. Ascorbic acid is a potent
enhancer of Fe absorption that can counteract the
inhibitory effect of phytic acid (Siegenberg et al.
1991). We have recently demonstrated a significant P ,
0´05 increase in Fe absorption by infants and adults
from soyabean formula after the degradation of phytic
acid, or by doubling the concentration of ascorbic acid in
DOI: 10.1079/BJN2000232British Journal of Nutrition (2001), 85, 59±63
q Nutrition Society 2001
Abbreviation: Hb, haemoglobin.
* Corresponding author: Lena Davidsson, fax +41 1 704 5710, email davidsson@ilw.agrl.ethz.ch
https:/www.cambridge.org/core/terms. https://doi.org/10.1079/BJN2000232
Downloaded from https:/www.cambridge.org/core. University of Basel Library, on 30 May 2017 at 22:16:46, subject to the Cambridge Core terms of use, available at
the native phytic-acid-containing formula (Davidsson
et al. 1994; Hurrell et al. 1998).
The aim of the present study was to evaluate Fe
absorption in adult women from experimental infant
formulas based on pea protein. The effect of phytic acid
degradation and the effect of an increased ascorbic acid
content were investigated, using a stable-isotope technique
based on erythrocyte incorporation of Fe stable-isotope
labels 14 d after administration.
Materials and methods
Infant formulas
Semper AB (Stockholm, Sweden) produced experimental
infant formulas based on pea-protein isolate for the study.
Except for the protein source, the overall composition and
processing of the experimental products were similar to
those for a commercial soyabean infant formula (Soja
Semp; Semper AB). Two different experimental products
were prepared as liquid `ready-to-feed' formulas without
any added Fe or ascorbic acid. Commercial pea-protein
isolate (Provital Industrie SA, Warcoing, Belgium) was
used for production of an experimental infant formula with
the native content of phytic acid (product 1), while product
2 was based on dephytinised pea-protein isolate. Dephyti-
nised pea-protein isolate was prepared by the addition of
commercial phytase (Phytase Novo L; Novo Nordisk,
Copenhagen, Denmark) to commercial pea-protein isolate,
using a process similar to that previously described for
soyabean isolate (Davidsson et al. 1994). The microbiolo-
gical safety and the nutritional composition of the products
were assured before release from the factory according to
the control system used for commercial infant formulas.
Subjects
Twenty healthy women (ten per study) were recruited for
the study from the student population and staff at the Swiss
Federal institute of Technology and the University of
ZuÈrich. Exclusion criteria included pregnancy or lactation
as well as subjects with gastrointestinal disorders or
metabolic diseases. No medication (except oral contra-
ceptives) or vitamin±mineral supplements were allowed
during the study. Volunteers were fully informed about the
aims and the procedures of the study both verbally and in
writing and written informed consent was obtained. The
study protocol was reviewed and approved by the Ethical
Committee at the University Hospital, ZuÈrich.
Study protocol
A baseline venous blood sample (7 ml) was drawn in
EDTA-treated Vacutainer tubes (Becton Dickinson Vacu-
tainer Systems, Europe, Meylan, France) for determination
of haemoglobin (Hb) and ferritin on the first day of the
study. Body weight and height were measured and a
questionnaire regarding previous illnesses, medication and
food habits was completed. Administration of labelled test
meals was done in the morning on four consecutive days,
after an overnight fast. Women were randomly allocated to
study 1 or 2. The standardised study protocol was identical
to that previously used by us and each labelled test meal
consisted of 217 g liquid infant formula (Hurrell et al.
1998). The two different test meals (A and B) within each
study were administered in the order ABAB or BABA. Five
women in each study started with test meal A and the other
five women with test meal B. Fe stable-isotope labels and
ascorbic acid (Merck, Darmstadt, Germany) were added to
the liquid test meals as solutions immediately before intake
(Table 1). The administrations of labelled test meals were
done under close supervision by the investigators. No food
or fluid was allowed for 3 h following intake of labelled
test meals. A second blood sample (7 ml) was drawn on
day 19 for analysis of Fe stable-isotope composition and
Hb.
Blood analysis
Blood samples were analysed for Hb by cyanomethaemo-
globin technique (Sigma kit; Sigma, St Louis, MO, USA)
and for Fe isotopic composition (see p. 61). Plasma was
separated from an aliquot of the whole blood and analysed
for ferritin (ELISA kit; Ramco, Houston, TX, USA).
Quality-control materials for Hb (Dia-HT1-2-3; DiaMed,
Cressier sur Morat, Switzerland) and ferritin (Ferritin
Assay Control Serum; Ramco) were analysed together
with the samples.
Stable-isotope labels
Isotopically-labelled FeSO4 solutions were prepared from
isotopically-enriched elemental Fe by dissolution of the
metal in 0´1 M-H2SO4. The isotopic composition of Fe in
solution was determined by negative-thermal-ionisation
MS using a magnetic-sector-field instrument (MAT 262;
Finnigan MAT, Bremen, Germany). Fe concentrations of
the solutions were determined by isotope-dilution MS v. an
Fe standard, prepared gravimetrically from an isotopic
Table 1. Study protocol for the administration of labelled test meals based on pea (Pisum sativum)-protein-
isolate infant formula
Study Test meal Phytic acid content Fe stable isotope Molar ratio Fe : ascorbic acid
1 A Native 57Fe 1 : 2´1
B Dephytinised* 58Fe 1 : 2´1
2 A Native 57Fe 1 : 2´1
B Native* 58Fe 1 : 4´2
* Commercial pea-protein isolate was dephytinised by the addition of commercial phytase (Phytase Novo; Novo Nordisk,
Copenhagen, Denmark), as described by Davidsson et al. (1994) for soyabean-protein isolate.
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reference material (IRM-014; Institute of Reference
Materials and Measurements, Geel, Belgium).
Individual doses of isotopic labels (2´0 mg 57Fe or
2´0 mg 58Fe per test meal; total dose 4´0 mg 57Fe and
4´0 mg 58Fe per subject) were prepared by weighing the
corresponding amount of isotopically-labelled Fe solution
into Teflon containers, which were flushed with Ar to keep
the Fe in the Fe2+ oxidation state.
Iron isotopic analysis of blood samples
For all experimental work, the guidelines for trace element
analysis were strictly followed, including additional
purification of commercial chemicals and reagents and
acid-washing of all containers used during trace element
analysis. All handling of samples was done under clean
laboratory conditions to reduce the risk of sample
contamination during analysis.
Each isotopically-enriched blood sample was analysed in
duplicate for its Fe isotopic composition under chemical
blank monitoring. Whole-blood samples were mineralised
using an HNO3±H2O2 mixture (5 : 2, v/v) and microwave
digestion. Sample Fe was separated from the matrix by
anion-exchange chromatography following a solvent±
solvent extraction step into diethyl ether (Beer & Heumann,
1993; Kastenmayer et al. 1994; Walczyk et al. 1997). All
isotopic analyses were performed using a magnetic-sector-
field MS (MAT 262; Finnigan MAT) equipped with a
multi-collector system for simultaneous ion-beam detec-
tion. For Fe isotope-ratio measurements, the recently-
developed negative-thermal-ionisation MS technique
(Walczyk, 1997) was used. Fe separated from the sample
was loaded on BaF2-coated Re filaments of a double-
filament ion source together with AgF to promote the
formation of negatively-charged FeF4
2 ions. Based on the
high enrichment of the isotopically-enriched labels and
the low amounts of labels expected to be incorporated into
the erythrocytes it was possible to normalise the acquired
isotopic data for the natural 54Fe : 56Fe isotope ratio (Taylor
et al. 1992).
Calculation of iron absorption
Based on the shift of Fe stable-isotope ratios in the blood
samples and circulating Fe, the amount of 57Fe isotopic
label and 58Fe isotopic label present in the blood of each
study subject 14 d after test meal administration was
calculated. Calculations were based on the principles of
isotope dilution, taking into consideration that the Fe
isotopic labels were not monoisotopic (Walczyk et al.
1997). Circulating Fe was calculated based on blood
volume and Hb concentration (Kastenmayer et al. 1994).
Blood volume calculations were based on height and
weight following empirically-derived formulas (Brown
et al. 1962). For calculation of fractional absorption,
80 % incorporation of the absorbed Fe into erythrocytes
was assumed.
Food analysis
Food samples were mineralised by microwave digestion
(MLS 1200; MLS GmbH, Leutkirch, Germany) in a
HNO3±H2O2 mixture and analysed for Fe and Ca by
electrothermal±flame atomic absorption spectroscopy
(SpectrAA 400; Varian, Mulgrave, Australia) using the
standard addition technique to minimise matrix effects.
Phytic acid analysis myo-inositol triphosphate to myo-
inositol hexaphosphate was performed at the Department of
Food Science, Chalmers University of Technology, GoÈte-
borg, Sweden, according to the method of Skoglund et al.
(1997) with some modifications. Liquid samples (10 ml)
were extracted with 1 M-HCl (10 ml) for 3 h followed by
evaporation of 15 ml extract and dissolution in 0´025 M-
HCl (2 ml). The solution was centrifuged and 400 ml
supernatant fraction filtrated through Millipore Microcon
YM-30 centrifugal filter (Millipore AB, Sundbyberg,
Sweden). The filtrate was injected into the HPLC analysis
system, consisting of a biocompatible HPLC pump (Waters
Model 626; Waters Associates, Milford, MA, USA), 50 ml
injector loop, a HPIC Omni Pac PAX-100 4  250 mm
analytical column, a PAX-100 4  50 mm guard column
(Dionex Corp., Sunnyvale, CA, USA), and Waters 486
tunable absorbance detector (Waters Associates).
Protein content was based on analysis of N, using a
standard Kjeldahl technique, and applying the factor 6´25 to
convert N content to protein.
Statistics
Paired t test was used for the evaluation of Fe absorption in
both studies. Values were log transformed before statistical
analysis. Results are presented as geometric means and
+1SD and 21SD.
Results
The protein content of the two experimental formulas based
on pea protein (native phytic acid v. dephytinised) was
20´4 g/l v. 18´4 g/l. The corresponding concentrations (mg/
l) of Fe and Ca were 3´6 v. 3´0 and 343 v. 334 respectively
in the two products. Phytic acid content was 513 mmol/l v.
,1 mmol/l respectively in the two products.
Twenty women (mean age 22 (range 20±28) years, mean
body weight 55 (range 48±62) kg) participated in the two
studies. Mean Hb was 138 (range 123±155) g/l for study 1
and 145 g/l (range 136±150) g/l for study 2. The geometric
mean (and range) plasma ferritin concentration was 13 (5±
28) mg/l for study 1 and 10 mg/l (6±27) mg/l for study 2.
Four and six women had low Fe stores, as indicated by
plasma ferritin ,12 mg/l in studies 1 and 2 respectively.
In study 1 Fe absorption increased significantly after the
degradation of phytic acid; geometric mean Fe absorption
increased from 20´7 (+1SD 41´6, 21SD 10´3) % to 33´1
(+1SD 58´6, 21SD 18´7) %; P , 0´0001. Doubling the
molar ratio Fe:ascorbic acid in study 2 also increased Fe
absorption significantly; geometric mean Fe absorption
increased from 14´8 (+1SD 32´1, 21SD 6´8) % to 22´1 (+1SD
47´2, 21SD 10´4) %; P , 0´0001:
Discussion
Recent studies on Fe bioavailability from soyabean
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formulas have reported a significant increase in Fe
absorption by infants and adults after phytic acid degrada-
tion or by doubling the concentration of ascorbic acid in the
formula containing native phytic acid (Davidsson et al.
1994; Hurrell et al. 1998). The results from the present
study confirm these earlier observations and clearly
demonstrate that Fe bioavailability from infant formula
based on pea-protein isolate can also be improved by phytic
acid degradation or by increased addition of ascorbic acid.
The present study was implemented in women and not in
infants since the experimental infant formulas used in the
present study have not yet been evaluated in infant growth
studies or tested for acceptability in infants. Fe absorption
studies in adults, however, have been demonstrated to be a
valuable tool for evaluating the influence of phytic acid and
ascorbic acid on Fe absorption from infant formulas in
infants (Hurrell et al. 1998).
Fractional Fe absorption by young women from the
experimental infant formulas based on pea-protein isolate
was relatively high, compared with earlier data on Fe
absorption by young adults from soyabean formulas
(Hurrell et al. 1998). Using a radioisotopic technique we
have previously reported geometric mean Fe absorption
values of 2´4 and 6´0 % respectively from soyabean
formula with native phytic acid content or dephytinised.
After doubling the ascorbic acid concentration, geometric
mean Fe absorption increased from 4´1 % to 5´3 % (Hurrell
et al. 1998). The soyabean formulas contained similar
amounts of Fe and ascorbic acid to the pea-protein formulas
and were fed in 217 g servings with an identical study
design, except that radioisotopes were used instead of
stable-isotope labels of Fe. Due to the pronounced inter-
individual variation in Fe absorption resulting from
differences in Fe status, it is not possible to compare
directly data from different studies. Serum ferritin con-
centration has a close inverse relationship with Fe
absorption (Cook et al. 1974; Walters et al. 1975;
Magnusson et al. 1981) and several of the women
participating in the present study had low plasma ferritin
concentrations, while the geometric mean ferritin value for
the young women and men participating in the soyabean-
formula study was about 35 mg/l (Hurrell et al. 1998).
Studies can be compared, however, if the Fe absorption
values are adjusted to comparable Fe status. Since the
formulas based on soyabean- and pea-protein isolates
contained different amounts of phytic acid, the most
relevant comparison is that between products based on
dephytinised protein isolates. Using the model proposed by
Cook et al. (1991), the individual Fe absorption data from
the pea-protein formulas used in study 1 were adjusted to
35 mg ferritin/l, resulting in a geometric mean Fe
absorption of 7´8 % v. 12´3 % (native phytic acid content
v. dephytinised). Thus, these results indicate that dephyti-
nised pea protein might be less inhibitory than dephytinised
soyabean protein (geometric mean Fe absorption 6´0 %;
Hurrell et al. 1998).
Lynch et al. (1994) reported that soyabean protein per se
was inhibitory to Fe absorption in human subjects and
identified the major protein fraction conglycinin as the
inhibitory component. Pea protein contains 55±57 %
globulins and 21±26 % albumins compared with 90 %
and 10 % respectively of the corresponding proteins in
soyabean (GueÂguen & LemarieÂ, 1996). The major proteins
in both soyabean and peas are globulins (type 7S and type
11S), but the globulin fractions are different. The globulins
in soyabean are b-conglycinin and g-conglycinin (7S) and
glycinin (11S), while pea protein contains vicilinin and
convicilinin (7S) and leguminin (11S). Pea protein does not
contain the conglycinin fraction shown to inhibit Fe
absorption in soyabean protein, and this difference in
protein composition could explain the higher fractional Fe
absorption from dephytinised pea-protein formula indicated
by our studies. Additional studies with direct comparisons
between dephytinised pea and dephytinised soyabean
protein would be required for a final evaluation of the
effect of these different protein sources per se on Fe
bioavailability.
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